Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.58 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.37 |
| ▸ | GAA | P10253 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 3/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2605173 | 0.96 | CYP3A4 (0.64) | CYP3A4NPSR1MAPTALDH1A1KMT2A | |
| Acetone SCHEMBL11800599 | 0.79 | CYP3A4 (0.76) | CYP3A4NPSR1MAPTALDH1A1KMT2A | |
| SCHEMBL12241417 | 0.78 | MEN1 (0.35) | KMT2AMEN1ATM | |
| SCHEMBL12580004 | 0.76 | CYP3A4 (0.64) | CYP3A4NPSR1MAPTALDH1A1KMT2A | |
| SCHEMBL12580005 | 0.76 | CYP3A4 (0.64) | CYP3A4NPSR1MAPTALDH1A1KMT2A | |
| SCHEMBL28662 | 0.75 | CYP3A4 (1.00) | CYP3A4NPSR1MAPTALDH1A1KMT2A | |
| SCHEMBL24669059 | 0.74 | CYP3A4 (0.76) | CYP3A4NPSR1MAPTALDH1A1KMT2A | |
| SCHEMBL29860820 | 0.72 | CYP3A4 (0.57) | CYP3A4NPSR1MAPTALDH1A1KMT2A | |
| SCHEMBL10997976 | 0.71 | CYP3A4 (0.79) | CYP3A4NPSR1MAPTALDH1A1KMT2A | |
| SCHEMBL19722545 | 0.71 | CYP3A4 (0.55) | CYP3A4NPSR1MAPTALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120095225-A1 | METHOD OF STORING TRIALLYL ISOCYANURATE | NIPPON KASEI CHEMICAL COMPANY LIMITED (JP) | 2012-04-19 | — | — | US | disclosed |
| US-20120095223-A1 | TRIALLYL ISOCYANURATE, TRIALLYL CYANURATE AND PROCESS FOR PRODUCING TRIALLYL ISOCYANURATE | NIPPON CHEMICAL COMPANY LIMITED (JP) | 2012-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120095225-A1 | METHOD OF STORING TRIALLYL ISOCYANURATE | TIMCC, TST, TMT1A | CYP3A4 3374/4885NPSR1 3396/4885MAPT 1336/4885 |
| US-20120095223-A1 | TRIALLYL ISOCYANURATE, TRIALLYL CYANURATE AND PROCESS FOR PRODUCING TRIALLYL ISOCYANURATE | CA9, CROCC, CA2 | CYP3A4 472/4885NPSR1 1596/4885MAPT 3564/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.